Jonathan Ko Email & Phone Number
@steminent.com
LinkedIn matched
Who is Jonathan Ko? Overview
A concise factual answer block for searchers comparing this professional profile.
Jonathan Ko is listed as Senior Vice President at Steminent Biotherapeutics, a with 21 employees, based in Taipei, Taipei City, Taiwan, Province of China. AeroLeads shows a work email signal at steminent.com and a matched LinkedIn profile for Jonathan Ko.
Jonathan Ko previously worked as Vice President at Steminent Biotherapeutics and ITRI 生醫所 特聘研究 at 工研院. Jonathan Ko holds Doctor Of Philosophy (Ph.D.), Pharmaceutical Sciences from 臺北醫學大學.
Email format at Steminent Biotherapeutics
This section adds company-level context without repeating Jonathan Ko's masked contact details.
AeroLeads found 1 current-domain work email signal for Jonathan Ko. Compare company email patterns before reaching out.
About Jonathan Ko
Experienced Vice President in the venture capital and private equity industry, and also experienced principle investigator in bioindustry. Skilled in Biotechnology, In Vitro analysis, Drug Development, Cancer Biology, and medical applied technology. Strong professional with a Doctor of Philosophy (Ph.D.) focused in Pharmaceutical Sciences from Taipei Medical University.
Listed skills include Teamwork, Team Building, Project Management, Biotechnology, and 11 others.
Jonathan Ko's current company
Company context helps verify the profile and gives searchers a useful next step.
Jonathan Ko work experience
A career timeline built from the work history available for this profile.
Vice President
Current
Itri 生醫所 特聘研究
Current
Board Member
Board Member
Board Member
Vice President
- CDIB Capital Management - CDIB Capital Healthcare Ventures Limited- CDIB Capital Healthcare Ventures II L.P.- Healthcare fund investments and manage: Leading innovative biotechnologies- Participate in CDIB health care funds raising- Projects reviewer in academia & government- Mentor in startup programs & accelerators
Assistant Vice President
Special/Executive Assistant To Gm
- IVD business (TBG Biotechnology Corp) Spin-off from Medigen- Strategic business planning/ Project evaluation/ Due diligence- Resource integration/commercialization/market analysis/business alliance & collaboration- Connect/utilize different capabilities and resources- IRB planning/execution with clinical evaluations - Executive secretary in Taiwan Molecular diagnosis Alliance (台灣生醫分子檢測產業聯盟)
Senior Researcher & Manager
- Principle investigator in Strategic Business & Innovation Technology Development Division. - Principle Investigator in Drug/ cell application/ medical device associated projects- Innovative, translatable researches exhibited from bench to clinics - Task force team buildup (8 members) for drug/cell application/medical device development: Molecular targeting/Drug screening/ Cancer stem cells /Signal transduction/ Tyrosine kinases/ PD-PK correlation/ novel cell applications- Well-established partnership with KOLs and clinicians in both academia and industries- Construct/connect the industry R&D value chain capability, including platform and core service facilities- Drug discovery, development and technology transfer: ITRI-260, a new drug for AML treatment (to Anchen Biopharm 安成- RuenHuei Biopharm潤惠)- Medical device development and technology transfer (pre-participation): Automatic processing device for adipose tissue-derived stem cell (Gemmy industrial Corp. 璟明實業)- Cell Line establishment: 2 novel, unique HCV-related hepatocellular carcinoma cell lines establishment- Invited speaker, 2012 International Symposium on Recent Advances in Stem Cells and Cancer & The 8th Annual Meeting of TSSCR: Cancer stem cell study in hepatocellular carcinoma
Researcher/ Project Leader
- Principle investigator in cell engineering lab. - Principle investigator in various Technology Development Programs, including small molecule drug development, herbal medicine development, medical device,regeneration medicine, stem cell technology and companion diagnostics. - Task force team buildup for oncology and translation projects, including molecular targeting, drug screening, cancer stem cells, signal transduction, tyrosine kinase/receptors, molecular markers for diagnosis and prognosis.
Project Leader
— Projects dual diligence: potential new drug/medical device projects evaluation for a clearer commercialization path— Establish drug development value chain for Liver cancer/Lung cancer: potential new drugs can employ this value chain to improve their commercialization success rate— Built up the connection between KOLs, clinicians, research/medical centers, infrastructures, National Science Council, and National Research Program for Biopharmaceuticals (NRPB).— Bridge up between academia and industry and promote to speed up in the commercialization process
Colleagues at Steminent Biotherapeutics
Other employees you can reach at steminent.com. View company contacts for 21 employees →
吳曉菁
Colleague at Steminent BiotherapeuticsTaiwan, Province Of China
View →
EY
En-Chia Yang
Colleague at Steminent BiotherapeuticsTaiwan, Province Of China
View →
HY
Huan Yun Wang
Colleague at Steminent BiotherapeuticsTaipei, Taipei City, Taiwan, Province Of China
View →
LW
Ling-Mei Wang
Colleague at Steminent BiotherapeuticsTaipei–Keelung Metropolitan Area, Taiwan, Province Of China
View →
PC
Po Cheng Cheng
Colleague at Steminent BiotherapeuticsNew Taipei City, Taiwan, Province Of China
View →
KS
Kuanming Sebastian Lu
Colleague at Steminent BiotherapeuticsTaipei–Keelung Metropolitan Area, Taiwan, Province Of China
View →
林
林怡君
Colleague at Steminent BiotherapeuticsTaiwan, Province Of China
View →
DW
Doris, Wei-Kee Ong
Colleague at Steminent BiotherapeuticsTaiwan, Province Of China
View →
YL
Yin Liang
Colleague at Steminent BiotherapeuticsTaiwan, Province Of China
View →
CH
Chien Hsin Lee
Colleague at Steminent BiotherapeuticsTaipei, Taipei City, Taiwan, Province Of China
View →
Jonathan Ko education
Doctor Of Philosophy (Ph.D.), Pharmaceutical Sciences
Master'S Degree, Natural Products Chemistry And Pharmacognosy
Bachelor'S Degree, Pharmacy
Frequently asked questions about Jonathan Ko
Quick answers generated from the profile data available on this page.
What company does Jonathan Ko work for?
Jonathan Ko works for Steminent Biotherapeutics.
What is Jonathan Ko's role at Steminent Biotherapeutics?
Jonathan Ko is listed as Senior Vice President at Steminent Biotherapeutics.
What is Jonathan Ko's email address?
AeroLeads has found 1 work email signal at @steminent.com for Jonathan Ko at Steminent Biotherapeutics.
Where is Jonathan Ko based?
Jonathan Ko is based in Taipei, Taipei City, Taiwan, Province of China while working with Steminent Biotherapeutics.
What companies has Jonathan Ko worked for?
Jonathan Ko has worked for Steminent Biotherapeutics, 工研院, Formosa Pharmaceuticals, Inc., Elixiron Immunotherapeutics, and Act Genomics 行動基因.
Who are Jonathan Ko's colleagues at Steminent Biotherapeutics?
Jonathan Ko's colleagues at Steminent Biotherapeutics include 吳曉菁, En-Chia Yang, Huan Yun Wang, Ling-Mei Wang, and Po Cheng Cheng.
How can I contact Jonathan Ko?
You can use AeroLeads to view verified contact signals for Jonathan Ko at Steminent Biotherapeutics, including work email, phone, and LinkedIn data when available.
What schools did Jonathan Ko attend?
Jonathan Ko holds Doctor Of Philosophy (Ph.D.), Pharmaceutical Sciences from 臺北醫學大學.
What skills is Jonathan Ko known for?
Jonathan Ko is listed with skills including Teamwork, Team Building, Project Management, Biotechnology, Cell, Oncology, Drug Development, and Cell Biology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Jonathan Ko you were looking for.
View similar profiles